Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from RTTNews

19:40 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "RTTNews" found in our extensive news archives from over 250 global news sources.

More Information about RTTNews on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about RTTNews for you to read. Along with our medical data and news we also list RTTNews Clinical Trials, which are updated daily. BioPortfolio also has a large database of RTTNews Companies for you to search.

Showing News Articles 1–25 of 439 from RTTNews

Friday 7th December 2018

NTEC Is Up 110% In 3 Months - Did You Ride The Rally?

Shares of Intec Pharma Ltd. (NTEC) touched a new 52-week high of $8.08 on Thursday, before closing the day's trading at $7.84, a gain of 110% in 3 months. The stock was trading around $3.85 when we alerted our premium subscribers to it on September 10, 2018. (Report titled "Is this stock on your radar?").

Thursday 6th December 2018

No Respite For MiMedx, CNAT Fails NASH Trial, NDRA On Watch

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

KOD Catches Eyes, MRNS On Watch, Mark Your Calendar For AQST

The following are some of today's top gainers in the pharma/biotech sector.

Wednesday 5th December 2018

Supernus Pharma To Report Phase III SPN-812 Data - Your Attention, Please

Supernus Pharmaceuticals Inc. (SUPN) is all set to report results from its two phase III studies of SPN-812 tomorrow, December 6, 2018, at approximately 7:00 a.m. ET.

Study Throws New Light On Cardiovascular Effectiveness Of Diabetes Drug Victoza

Novo Nordisk's (NVO) diabetes drug Victoza is linked to lower risk of myocardial infarction, stroke or cardiovascular death in a broader patient population, suggests a Nordic study.

Tuesday 4th December 2018

FDA Nod For First Test To Detect Herpes Virus In Newborns

The first test to aid in detecting cytomegalovirus, a type of herpes virus, in newborns has received the FDA go-ahead.

Krystal Is Clearer, Hits New High

Shares of Krystal Biotech Inc. (KRYS) touched an all-time intraday high of $28.75 on Monday, a gain of 126% in six months. We had alerted our readers to this stock on June 8, 2018, when it as trading around $12.72 (Report titled: In The Spotlight: Krystal Biotech).

Monday 3rd December 2018

Aphria Shares Tumble After Short Seller Allegations

Shares of Aphria Inc. tumbled more than 23 percent in Tuesday's regular trading on the New York Stock Exchange after a short seller called the Canada-based medical cannabis company a "black hole" and alleged that the company's recent Latin American acquisitions appeared to be largely worthless. In response to the allegations, Aphria said it believes the short-seller report is malicious.

SNNA Plunges On Trial Results, TNXP Awaits RECOVERY, APHA Under Scanner?

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

GBT On Fast Track, GH In Good Health, For BHVN, It's All Gain, No Pain

The following are some of today's top gainers in the pharma/biotech sector.

Osmotica Pharma: Eye-catching Or Still Obscure?

Osmotica Pharmaceuticals plc (OSMT), which recently made its debut on the Nasdaq, is down 12% since its IPO while the iShares Nasdaq Biotechnology ETF (IBB) index has lost nearly 5% of its value for the same period.

XLRN On Watch, BPMC Makes An Imprint, Osteoporosis Drug Evenity Faces FDA Panel

Today's Daily Dose brings you news about miRagen's phase I trial results of Cobomarsen in mycosis fungoides patients; MEDALIST trial results; Apellis Pharma's paroxysmal nocturnal hemoglobinuria study results; Blueprint Medicines' EXPLORER trial results, and Celyad's progress in phase I trial of non-gene edited allogeneic CAR-T therapy.

Sunday 2nd December 2018

First Medical Marijuana Dispensaries Open In Iowa

Medical marijuana dispensaries have opened for the first time in Iowa on Saturday, December 1, 2018. Five medical cannabidiol or CBD dispensaries have opened for business in Sioux City, Council Bluffs, Windsor Heights, Waterloo and Davenport. MedPharma Iowa, Iowa's only medical cannabidiol manufacturer, will manufacture all of the state's legal marijuana products in Des Moines.

Thursday 29th November 2018

FDA Warns About Serious Side Effects Of Multiple Sclerosis Drug

The FDA is warning consumers about the risk of rare but serious cases of stroke and tears in the lining of arteries in the head and neck associated with multiple sclerosis drug Lemtrada, chemically known as Alemtuzumab. These problems can lead to permanent disability and even death.

Recreational Marijuana To Become Legal In Michigan Next Week

The law legalizing cannabis for recreational use in Michigan will come into effect on December 6, 2018, nearly a month after the voters approved Proposal 1, the Michigan Regulation and Taxation of Marihuana Act, which called for the expansion of marijuana use.

Wednesday 28th November 2018

Massachusetts Marijuana Sales Top $2 Mln In First Five Days

Sales of marijuana products from the first recreational marijuana stores in Massachusetts have exceeded $2 million during the first five days of business. Massachusetts, which voted to legalize recreational marijuana in 2016, opened the first recreational marijuana stores on November 20. It thus became the first state along the U.S. east coast to allow the sale of the drug for recreational use.

HAIR Falls, NVCN Touches New Low, Mark Your Calendar For NDRA

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

ALQA's Subsidiary Enters Cannabis Space, TYME On Watch, VXRT Turning Heads

The following are some of today's top gainers in the pharma/biotech sector.

Catalysts That Could Move Catalyst Pharma

Shares of Catalyst Pharmaceuticals Inc. (CPRX) have lost 26% of their value so far this year while the iShares Nasdaq Biotechnology ETF (IBB) has fallen about 2.6% during the same period.

New Jersey Moves One Step Closer To Recreational Marijuana Legalization

After missing the October deadline to vote on a bill to legalize recreational marijuana, New Jersey, the Garden State, on Monday, moved one step closer, with a House-Senate committee in the State Legislature approving the marijuana legalization bill.

Tuesday 27th November 2018

ASNS Turning Heads, SPHS To Report Data In Dec., Mark Your Calendar For COCP

The following are some of today's top gainers in the pharma/biotech sector.

Vertex: Two Phase 3 Studies Of VX-659 Triple Combination Met Primary Endpoint

Vertex Pharmaceuticals Inc. (VRTX) said Tuesday that two Phase 3 studies of the triple combination of the next-generation corrector VX-659, Tezacaftor and Ivacaftor met the primary endpoint of improvement in lung function in people with cystic fibrosis or CF.

Monday 26th November 2018

ZFGN Hit By Clinical Hold, EQ For The Long Haul, MBOT On Watch

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.

NVIV Hopes To INSPIRE, SENS Making Sense, TYME To Report Phase 2 Data In Jan.

The following are some of today's top gainers in the pharma/biotech sector.

Vir Biotechnology, Alnylam Start Phase 1/2 Study Of VIR-2218 - Quick Facts

Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. (ALNY) said Monday that they have initiated a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference or RNAi therapeutic for the treatment of chronic hepatitis B virus or HBV infection.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks